Literature DB >> 12490729

A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs.

Robert Padilla1, Rui Sousa.   

Abstract

A T7 RNA polymerase in which Tyr639 is mutated to Phe readily utilizes 2'-deoxy, 2'-NH2 and 2'-F NTPs as substrates and has been widely used to synthesize modified RNAs for a variety of applications. This mutant does not readily utilize NTPs with bulkier 2'-substituents, nor does it facilitate incorporation of NTPs with modifications at other positions. Introduction of a second mutation (H784A) into the Y639F background markedly enhances utilization of NTPs with bulky 2'-substituents (2'-OMe and 2'-N3), and may also enhance use of NTPs with modifications at other than the 2'-position. The Y639F/H784A double mutant may therefore be exceptionally useful for incorporation of a variety of non-canonical NMPs into RNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490729      PMCID: PMC140087          DOI: 10.1093/nar/gnf138

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  10 in total

1.  Chemical probing of RNA by nucleotide analog interference mapping.

Authors:  S P Ryder; L Ortoleva-Donnelly; A B Kosek; S A Strobel
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Characterization of halted T7 RNA polymerase elongation complexes reveals multiple factors that contribute to stability.

Authors:  P E Mentesana; S T Chin-Bow; R Sousa; W T McAllister
Journal:  J Mol Biol       Date:  2000-10-06       Impact factor: 5.469

3.  Roles of histidine 784 and tyrosine 639 in ribose discrimination by T7 RNA polymerase.

Authors:  L G Brieba; R Sousa
Journal:  Biochemistry       Date:  2000-02-08       Impact factor: 3.162

4.  Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2'-groups using a mutantT7 RNA polymerase (RNAP).

Authors:  R Padilla; R Sousa
Journal:  Nucleic Acids Res       Date:  1999-03-15       Impact factor: 16.971

5.  Mechanism of ribose 2'-group discrimination by an RNA polymerase.

Authors:  Y Huang; F Eckstein; R Padilla; R Sousa
Journal:  Biochemistry       Date:  1997-07-08       Impact factor: 3.162

6.  Structure of a transcribing T7 RNA polymerase initiation complex.

Authors:  G M Cheetham; T A Steitz
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

7.  A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth.

Authors:  M Sioud; D R Sørensen
Journal:  Nat Biotechnol       Date:  1998-06       Impact factor: 54.908

8.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates.

Authors:  J F Milligan; D R Groebe; G W Witherell; O C Uhlenbeck
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

9.  A bacteriophage T7 RNA polymerase/promoter system for controlled exclusive expression of specific genes.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

10.  A mutant T7 RNA polymerase as a DNA polymerase.

Authors:  R Sousa; R Padilla
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

  10 in total
  39 in total

Review 1.  The Toolbox for Modified Aptamers.

Authors:  Sergey A Lapa; Alexander V Chudinov; Edward N Timofeev
Journal:  Mol Biotechnol       Date:  2016-02       Impact factor: 2.695

2.  2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors.

Authors:  Youngju Lee; Johannes H Urban; Li Xu; Bruce A Sullenger; Jaewoo Lee
Journal:  Nucleic Acid Ther       Date:  2016-01-20       Impact factor: 5.486

Review 3.  In vitro selection using modified or unnatural nucleotides.

Authors:  Scott M Knudsen; Michael P Robertson; Andrew D Ellington
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2002-02

Review 4.  Aptamers as Therapeutics.

Authors:  Shahid M Nimjee; Rebekah R White; Richard C Becker; Bruce A Sullenger
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-01-06       Impact factor: 13.820

5.  Effect of Chemical Modifications on Aptamer Stability in Serum.

Authors:  Christina Kratschmer; Matthew Levy
Journal:  Nucleic Acid Ther       Date:  2017-09-25       Impact factor: 5.486

6.  Highly stable aptamers selected from a 2'-fully modified fGmH RNA library for targeting biomaterials.

Authors:  Adam D Friedman; Dongwook Kim; Rihe Liu
Journal:  Biomaterials       Date:  2015-01       Impact factor: 12.479

Review 7.  Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.

Authors:  Yi Shu; Mathieu Cinier; Dan Shu; Peixuan Guo
Journal:  Methods       Date:  2011-02-12       Impact factor: 3.608

Review 8.  Dynamics: the missing link between structure and function of the viral RNA-dependent RNA polymerase?

Authors:  Craig E Cameron; Ibrahim M Moustafa; Jamie J Arnold
Journal:  Curr Opin Struct Biol       Date:  2009-11-10       Impact factor: 6.809

9.  A T7 RNA Polymerase Mutant Enhances the Yield of 5'-Thienoguanosine-Initiated RNAs.

Authors:  Seth Lyon; Venkat Gopalan
Journal:  Chembiochem       Date:  2017-12-07       Impact factor: 3.164

10.  In vitro RNA SELEX for the generation of chemically-optimized therapeutic RNA drugs.

Authors:  Kevin T Urak; Sabrina Shore; William M Rockey; Shi-Jie Chen; Anton P McCaffrey; Paloma H Giangrande
Journal:  Methods       Date:  2016-03-10       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.